[HTML][HTML] TRPC3, but not TRPC1, as a good therapeutic target for standalone or complementary treatment of DMD

A Creisméas, C Gazaille, A Bourdon… - Journal of translational …, 2021 - Springer
Background Duchenne muscular dystrophy (DMD) is an X-linked inherited disease caused
by mutations in the gene encoding dystrophin that leads to a severe and ultimately life …

TRPC3, but not TRPC1, as a good therapeutic target for standalone or complementary treatment of DMD

A Creisméas, C Gazaille… - Journal of …, 2021 - nantes-universite.hal.science
Background Duchenne muscular dystrophy (DMD) is an X-linked inherited disease caused
by mutations in the gene encoding dystrophin that leads to a severe and ultimately life …

[HTML][HTML] TRPC3, but not TRPC1, as a good therapeutic target for standalone or complementary treatment of DMD

A Creisméas, C Gazaille, A Bourdon… - Journal of …, 2021 - ncbi.nlm.nih.gov
Background Duchenne muscular dystrophy (DMD) is an X-linked inherited disease caused
by mutations in the gene encoding dystrophin that leads to a severe and ultimately life …

TRPC3, but not TRPC1, as a good therapeutic target for standalone or complementary treatment of DMD

A Creisméas, C Gazaille, A Bourdon… - Journal of Translational …, 2021 - hal.science
Background Duchenne muscular dystrophy (DMD) is an X-linked inherited disease caused
by mutations in the gene encoding dystrophin that leads to a severe and ultimately life …

TRPC3, but not TRPC1, as a good therapeutic target for standalone or complementary treatment of DMD

A Creisméas, C Gazaille, A Bourdon… - Journal of …, 2021 - hal.univ-smb.fr
Background Duchenne muscular dystrophy (DMD) is an X-linked inherited disease caused
by mutations in the gene encoding dystrophin that leads to a severe and ultimately life …

[HTML][HTML] TRPC3, but not TRPC1, as a good therapeutic target for standalone or complementary treatment of DMD

A Creisméas, C Gazaille… - Journal of …, 2021 - … -medicine.biomedcentral.com
Duchenne muscular dystrophy (DMD) is an X-linked inherited disease caused by mutations
in the gene encoding dystrophin that leads to a severe and ultimately life limiting muscle …

[PDF][PDF] TRPC3, but not TRPC1, as a good therapeutic target for standalone or complementary treatment of DMD

A Creisméas, C Gazaille, A Bourdon… - Journal of Translational …, 2021 - d-nb.info
Background: Duchenne muscular dystrophy (DMD) is an X‑linked inherited disease caused
by mutations in the gene encoding dystrophin that leads to a severe and ultimately life …

TRPC3, but not TRPC1, as a good therapeutic target for standalone or complementary treatment of DMD

A Creisméas, C Gazaille, A Bourdon… - Journal of …, 2021 - hal.umontpellier.fr
Background Duchenne muscular dystrophy (DMD) is an X-linked inherited disease caused
by mutations in the gene encoding dystrophin that leads to a severe and ultimately life …

TRPC3, but not TRPC1, as a good therapeutic target for standalone or complementary treatment of DMD

A Creisméas, C Gazaille, A Bourdon… - Journal of …, 2021 - search.proquest.com
Background Duchenne muscular dystrophy (DMD) is an X-linked inherited disease caused
by mutations in the gene encoding dystrophin that leads to a severe and ultimately life …

TRPC3, but not TRPC1, as a good therapeutic target for standalone or complementary treatment of DMD

A Creisméas, C Gazaille, A Bourdon, MA Lallemand… - 2021 - agris.fao.org
English. Background Duchenne muscular dystrophy (DMD) is an X-linked inherited disease
caused by mutations in the gene encoding dystrophin that leads to a severe and ultimately …